Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.

"Conflict of interest statement A.T. has received grants and personal fees from Bayer, grants and personal fees from Baxter, grants and personal fees from Biotest, grants and personal fees from CSL Behring, grants and personal fees from Novo Nordisk, grants and personal fees from Pfizer, and grants and personal fees from Octapharma, during the conduct of the study. C.F.P. has received grants as bureau speaker, consultant, or advisor, from Gilead, Merck Sharp and Dohme, Roche, Pfizer, Abbott, Bristol-Myers Squibb, VIIV, and Boehringer-Ingelheim. None of these personal activities is in conflict with the opinions he expressed in this manuscript. D.N. has received honoraria for conferences from Pfizer, Roche Pharma, Roche Diagnostics, Abbott, MSD, and Astellas. G.D.M. has disclosed the following financial relationships — speaker or a member of a speaker bureau for: Boehringer-Ingelheim, Sanofi-Aventis, Bayer, Novo Nordisk, Pfizer, Biotest, and Grifols. Consultant or ad hoc speaker/consultant for: Boehringer-Ingelheim, Eli-Lilly, Sanofi-Aventis, Bayer, CSL Behring, Novo Nordisk, Pfizer, Biotest, and Grifols. J.W.I. has received personal fees from Piramal and grants from the Department of Health, UK, outside the submitted work. L.G. reports no potential conflicts of interest. M.C. has received research grants, lecture fees, and honoraria for consultancy from Baxter, Bayer, and Pfizer."

"Funding for medical writing assistance and two author meetings were provided by 10.13039/100004319Pfizer. Pfizer had no editorial influence regarding the contents of this manuscript and did not comment on the outline or any drafts prior to journal submission."